Vascular Graft Solutions
A new standard in coronary and peripheral bypass surgeries, arterial reconstruction and arteriovenous fistula repair
A new standard in coronary and peripheral bypass surgeries, arterial reconstruction and arteriovenous fistula repair
**Vascular Graft Solutions** (VGS) aims to revolutionize coronary and peripheral bypass surgeries, arterial reconstruction, and arteriovenous fistula repair. Founded in **2009** and headquartered in **Israel**, the company focuses on developing and commercializing innovative solutions to enhance bypass surgery outcomes. Its flagship product, the **VEST (Venous External Scaffolding Technology)**, serves as an external mechanical support for autologous vein grafts, effectively improving vein graft longevity by optimizing hemodynamics and mitigating vein graft disease. Notably, randomized controlled trials and real-world data studies in Europe have confirmed the significant biomechanical impact of external stenting, resulting in improved clinical outcomes. In **June 2018**, Vascular Graft Solutions secured a **Series B investment** led by **Champel Capital**, indicating confidence in the company's pioneering approach to vascular healthcare.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series B | Unknown | 1 |
|
03 Jun 2018 |
| Series B | $2.00M | 1 |
|
01 Feb 2014 |
| Debt Financing | $1.00M | 1 |
|
01 Feb 2012 |
| Grant | $300.00K | - | 10 Jul 2011 | |
| Series A | $1.50M | 1 |
|
01 Jan 2011 |
No recent news or press coverage available for Vascular Graft Solutions.
We care about your data, and we'd love to use cookies make your experience better.
